UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended  May 31, 2017

 

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ______________ to ______________

 

Commission File No. 333-1921663

 

GRIPEVINE INC.

(Formerly Baixo Relocation Services, Inc.)

(Exact Name of Small Business Issuer as specified in its charter)

 

Nevada

35-2511643

(State or Other Jurisdiction of Incorporation or Organization)

(I.R.S. Employer Identification No.)

 

1282A Cornwall Road

Oakville, Ontario

Canada

 

L6J 7W51

(Address of principal executive offices)

 

(Zip Code)

 

(416) 230-8805

Registrant’s telephone number, including area code

 

Not applicable

Former name, former address and former fiscal year, if changed since last report

 

Check whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x   No  ¨ .

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes  x No ¨  

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.

 

Large accelerated filer

¨

Accelerated filer

o

Non-accelerated filer

¨

Smaller reporting company

x

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  ¨ No  x

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the most practicable date:

 

Class

 

Outstanding as of July 14, 2017

Common Stock, $0.001

 

120,000,000

 

 
 
 
 

GRIPEVINE INC. (FORMERLY BAIXO RELOCATION SERVICES, INC.)

FORM 10-Q

FOR THE PERIOD ENDED MAY 31, 2017

 

INDEX

 

 

Page

 

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

3

 

PART I. FINANCIAL INFORMATION

 

Item 1.

Unaudited Condensed Combined Financial Statements

4

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

5

Item 3.

Qualitative and Quantitative Disclosures About Market Risk

10

Item 4.

Controls and Procedures

11

 

PART II. OTHER INFORMATION

 

Item 1.

Legal Proceedings

12

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

12

Item 3.

Defaults Upon Senior Securities

13

Item 4.

Mine Safety Disclosure

13

Item 5.

Other information

13

Item 6.

Exhibits

14

 

SIGNATURES

15

 

 
2
 
Table of Contents

 

Forward-looking Statements

 

Information included in this Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (“Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (“Exchange Act”). This information may involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Gripevine, Inc. (the “Company”), to be materially different from future results, performance or achievements expressed or implied by any forward-looking statements. Forward-looking statements, which involve assumptions and describe future plans, strategies and expectations of the Company, are generally identifiable by use of the words “may,” “will,” “should,” “expect,” “anticipate,” “estimate,” “believe,” “intend,” or “project” or the negative of these words or other variations on these words or comparable terminology. These forward-looking statements are based on assumptions that may be incorrect, and there can be no assurance that these projections included in these forward-looking statements will come to pass. Actual results of the Company could differ materially from those expressed or implied by the forward-looking statements as a result of various factors. Except as required by applicable laws, the Company has no obligation to update publicly any forward-looking statements for any reason, even if new information becomes available or other events occur in the future.

 

 
3
 
Table of Contents

 

PART I. FINANCIAL INFORMATION

 

ITEM 1. INTERIM CONDENSED COMBINED FINANCIAL STATEMENTS

 

Condensed Combined Financial Statements

 

Gripevine, Inc.

 

For The Quarterly Period Ended May 31, 2017

 

 

4

 
Table of Contents

 

Gripevine, Inc.

Condensed Combined Financial Statements

For The Quarterly Period Ended May 31, 2017

  

Table of contents

 

Unaudited Condensed Combined Balance Sheets

 

F-2

 

Unaudited Condensed Combined Statements of Operations and Comprehensive Loss.

 

F-3

 

Unaudited Condensed Combined Statements of Cash Flows

 

F-4

 

Notes to Unaudited Condensed Combined Financial Statements

 

F-5 to F-11

 

F-1
 
Table of Contents

  

Gripevine, Inc.

CONDENSED COMBINED BALANCE SHEETS

AS AT MAY 31, 2017 AND FEBRUARY 28, 2017 (UNAUDITED)

(Expressed in US dollars)

 

 

 

As At May 31,

2017

 

 

As At February 28, 2017

 

 

 

$

 

 

$

 

CURRENT ASSETS

 

 

 

 

 

 

Cash

 

 

56,069

 

 

 

32,678

 

Prepaid and other receivables

 

 

17,574

 

 

 

20,281

 

Total current assets

 

 

73,643

 

 

 

52,959

 

 

 

 

 

 

 

 

 

 

Equipment [Note 5]

 

 

39,091

 

 

 

41,655

 

TOTAL ASSETS

 

 

112,734

 

 

 

94,614

 

 

 

 

 

 

 

 

 

 

CURRENT LIABILITIES

 

 

 

 

 

 

 

 

Accounts payable

 

 

26,329

 

 

 

22,325

 

Accrued liabilities

 

 

93,663

 

 

 

78,827

 

Loans payable [Note 6]

 

 

2,109,723

 

 

 

1,822,953

 

Due to related parties [Note 6]

 

 

166,975

 

 

 

178,906

 

Due to a shareholder [Note 6]

 

 

592,297

 

 

 

568,547

 

TOTAL LIABILITIES

 

 

2,988,987

 

 

 

2,671,558

 

 

 

 

 

 

 

 

 

 

STOCKHOLDERS' DEFICIENCY

 

 

 

 

 

 

 

 

Preferred stock, $0.001 par value, 20,000,000 authorized. 1,000,000 shares issued and outstanding as at May 31, 2017 and February 28, 2017 [Note 7]

 

 

1,000

 

 

 

1,000

 

Common stock, $0.0001 par value, 300,000,000 authorized, 120,000,000 shares issued and outstanding as at May 31, 2017 and February 28, 2017 [Note 7]

 

 

120,000

 

 

 

120,000

 

Common stock to be issued [Note 7]

 

 

5,249

 

 

 

5,249

 

Additional paid-in-capital

 

 

43,698,125

 

 

 

43,698,125

 

Accumulated other comprehensive income 

 

 

281,946

 

 

 

233,651

 

Accumulated deficit

 

 

(46,982,573 )

 

 

(46,634,969 )
Total stockholders' deficiency

 

 

(2,876,253 )

 

 

(2,576,944 )
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY

 

 

112,734

 

 

 

94,614

 

 

 

 

 

 

 

 

 

 

Commitments [Note 9]

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Subsequent events [Note 10]

 

 

 

 

 

 

 

 

 

See accompanying notes to unaudited condensed combined financial statements

 

 
F-2
 
Table of Contents

 

 

Gripevine, Inc.

CONDENSED COMBINED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

FOR THE THREE MONTHS ENDED MAY 31, 2017 AND 2016 (UNAUDITED)

(Expressed in US dollars)

 

 

 

For The Three Months Ended

May 31,

2017

 

 

For The Three Months Ended

May 31,

2016

 

 

 

$

 

 

$

 

 

 

 

 

 

 

 

REVENUE

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EXPENSES

 

 

 

 

 

 

 

 

Stock based compensation [Note 7]

 

 

 

 

 

9,673,603

 

Research and development expenses [Note 8]

 

 

250,952

 

 

 

189,566

 

General and administrative expenses

 

 

96,652

 

 

 

67,728

 

TOTAL OPERATING EXPENSES

 

 

347,604

 

 

 

9,930,897

 

 

 

 

 

 

 

 

 

 

Income taxes 

 

 

 

 

 

 

NET LOSS

 

 

347,604

 

 

 

9,930,897

 

 

 

 

 

 

 

 

 

 

Translation adjustment

 

 

48,295

 

 

 

24,417

 

 

 

 

 

 

 

 

 

 

COMPREHENSIVE LOSS

 

 

395,899

 

 

 

9,955,314

 

 

 

 

 

 

 

 

 

 

LOSS PER SHARE, BASIC AND DILUTED

 

 

0.003

 

 

 

0.083

 

 

 

 

 

 

 

 

 

 

WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING

 

 

120,000,000

 

 

 

120,000,000

 

 

See accompanying notes to unaudited condensed combined financial statements

 

 
F-3
 
Table of Contents

   

Gripevine, Inc.

CONDENSED COMBINED STATEMENTS OF CASH FLOWS

FOR THE THREE MONTHS ENDED MAY 31, 2017 AND 2016 (UNAUDITED)

(Expressed in US dollars)

 

 

 

For The Three Months Ended

May 31,

2017

 

 

For The Three Months Ended

May 31,

2016

 

 

 

$

 

 

$

 

CASH FLOWS FROM OPERATING ACTIVITIES

 

 

 

 

 

 

Net loss

 

 

(347,604 )

 

 

(9,930,897 )

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

 

 

Stock based compensation

 

 

 

 

 

9,673,603

 

Depreciation

 

 

5,914

 

 

 

2,672

 

 

 

 

 

 

 

 

 

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

Prepaid expenses and other receivables

 

 

2,500

 

 

 

(1,911 )
Accounts payable

 

 

4,335

 

 

 

554

 

Accrued liabilities

 

 

16,331

 

 

 

 

Net cash used in operating activities

 

 

(318,524 )

 

 

(255,979 )

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM INVESTING ACTIVITIES

 

 

 

 

 

 

 

 

Purchase of equipment

 

 

(4,123 )

 

 

(8,816 )
Net cash used in investing activities

 

 

(4,123 )

 

 

(8,816 )

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES

 

 

 

 

 

 

 

 

Loans payable

 

 

321,004

 

 

 

307,603

 

Due to related parties

 

 

(13,876 )

 

 

(81,993 )
Due to a shareholder

 

 

34,398

 

 

 

39,548

 

Net cash provided by financing activities

 

 

341,526

 

 

 

265,158

 

 

 

 

 

 

 

 

 

 

Effect of foreign currency translation

 

 

4,512

 

 

 

208

 

 

 

 

 

 

 

 

 

 

Net increase in cash during the period

 

 

18,879

 

 

 

363

 

 

 

 

 

 

 

 

 

 

Cash, beginning of period

 

 

32,678

 

 

 

23,926

 

Cash, end of period

 

 

56,069

 

 

 

24,497

 

 

See accompanying notes to unaudited condensed combined financial statements

 

 
F-4
 
Table of Contents

  

Gripevine, Inc.

Notes to Condensed Combined Financial Statements

For The Three Months Ended May 31, 2017

(Expressed in US dollars)

 

1. NATURE OF OPERATIONS

 

Gripevine, Inc. (formerly Baixo Relocation Services, Inc. (the "Company") was incorporated in the state of Nevada on January 7, 2014. The Company operated as a relocation service provider for clients moving to the State of Goa, India and ceased this business and engaged in developing and building an online resolution platform after the Share Exchange Agreement as explained in the subsequent paragraphs. The Company's fiscal year-end is February end.

 

MBE Holdings Inc. (“MBE”) was incorporated as a limited liability company on April 13, 2010 under the laws of the State of Delaware. MBE is engaged in research and development activities to offer an online complaint resolution platform for consumers and business, including ratings, reviews and polling’s. As such, its efforts to date have been devoted in building technology that enables access to this market through the development of a tangible product.

 

As explained in Note 7 to the combined financial statements, on February 28, 2017, the Company and MBE and the shareholders of MBE who collectively own 100% of MBE entered into and consummated transactions pursuant to a Share Exchange Agreement, whereby the Company agreed to issue to the MBE shareholders an aggregate of approximately 5,248,626 shares of its common stock, par value $0.001, in exchange for 100% of equity interests of MBE held by the MBE shareholders. As a result of the share exchange, MBE became a wholly owned subsidiary of Gripevine.

 

As a result of the Share Exchange Agreement, the acquisition transaction has been accounted for as a common control transaction in accordance with the Financial Accounting Standards Board (ASC 805-50, Business Combinations – Common control transactions). The Company has evaluated the guidance contained in ASC 805 with respect to the combinations among entities or businesses under common control and conclude that since the majority shareholder of the Company and MBE are same, therefore, this is a common control transaction and do not result in a change in control at the ultimate parent or the controlling shareholder level.

 

Consequently, common control transactions are not accounted for at fair value. Rather, common control transactions are generally accounted for at the carrying amount of the net assets or equity interests transferred. Any differences between the proceeds received or transferred and the carrying amounts of the net assets are considered equity transactions that would be eliminated in consolidation, and no gain or loss would be recognized in the financial statements of the ultimate parent. Resultantly, the financial position and the results of operations of Gripevine and MBE are combined together as if they were operating as one entity from the beginning.

 

2. BASIS OF PRESENTATION AND COMBINATION

 

The accompanying unaudited condensed combined financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“US GAAP”) for interim financial information and the Securities Exchange Commission (“SEC”) instructions to Form 10-Q and Article 8 of SEC Regulation S-X.  Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements and should be read in conjunction with the Company’s audited combined financial statements for the years ended February 28, 2017 and February 29, 2016 and notes thereto included in the Form 10-K filed with the SEC on June 14, 2017. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of combined financial position and results of operations for the interim periods presented have been reflected herein.  Operating results for the three months ended May 31, 2017, are not necessarily indicative of the results that may be expected for the year ending February 28, 2018.

 

 
F-5
 
Table of Contents

 

Gripevine, Inc.

Notes to Condensed Combined Financial Statements

For The Three Months Ended May 31, 2017

(Expressed in US dollars)

 

2. BASIS OF PRESENTATION AND COMBINATION (continued)

 

As explained above in Note 1 to the unaudited condensed combined financial statements, as a result of the Share Exchange Agreement, the acquisition transaction has been accounted for as a common control transaction in accordance with the Financial Accounting Standards Board (ASC 805-50, Business Combinations – Common control transactions). Consequently, the combined financial statements have been prepared as if the Company and MBE were a single organisation by the aggregation of their financial statements from the beginning of the previous period and the elimination of transactions and balances between them.

 

3. GOING CONCERN

 

The unaudited condensed combined financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The Company has incurred recurring losses from operations and as at May 31, 2017 and February 28, 2017 had a working capital deficiency of $2,915,344 and $2,618,599, respectively and an accumulated deficit of $46,982,573 and $46,634,969 respectively. Management anticipates the Company will attain profitable status and improve its liquidity through continued business development and additional debt or equity investment in the Company. The Company’s continued existence is dependent upon its ability to continue to execute its operating plan and to obtain additional debt or equity financing. There can be no assurance that the necessary debt or equity financing will be available, or will be available on terms acceptable to the Company, in which case the Company may be unable to meet its obligations. Should the Company be unable to realize its assets and discharge its liabilities in the normal course of business, the net realizable value of its assets may be materially less than the amounts recorded in the combined financial statements. The combined financial statements do not include any adjustments relating to the recoverability of recorded asset amounts that might be necessary should the Company be unable to continue in existence.

  

4. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Use of Estimates

 

The preparation of unaudited condensed combined financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the combined financial statements and the reported amounts of revenues and expenses during the reporting period. Areas involving significant estimates and assumptions include: deferred income tax assets and related valuation allowance and accruals. Actual results could differ from those estimates. These estimates are reviewed periodically, and, as adjustments become necessary, they are reported in earnings in the period in which they become known.

 

Loss Per Share

 

The Company has adopted the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 260-10 which provides for calculation of “basic” and “diluted” earnings per share. Basic earnings per share includes no dilution and is computed by dividing net income or loss available to common stockholders by the weighted average number of common shares outstanding for the period. Diluted earnings per share reflect the potential dilution of securities that could share in the earnings of an entity. Diluted earnings per share exclude all potentially dilutive shares if their effect is anti-dilutive. There were no potentially dilutive shares outstanding as at May 31, 2017 and 2016.

 

Fair Value of Financial Instruments

 

ASC 820 defines fair value, establishes a framework for measuring fair value and expands required disclosure about fair value measurements of assets and liabilities. ASC 820-10 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820-10 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:

 

 
F-6
 
Table of Contents

  

Gripevine, Inc.

Notes to Condensed Combined Financial Statements

For The Three Months Ended May 31, 2017

(Expressed in US dollars)

 

4. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

 

 

·

Level 1 – Valuation based on quoted market prices in active markets for identical assets or liabilities.

 

 

 

·

Level 2 – Valuation based on quoted market prices for similar assets and liabilities in active markets.

 

 

 

·

Level 3 – Valuation based on unobservable inputs that are supported by little or no market activity, therefore requiring management’s best estimate of what market participants would use as fair value.

 

In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the asset or liability.

 

Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments or interest rates that are comparable to market rates. These financial instruments include cash and accounts payable. The Company's cash, which is carried at fair value, is classified as a Level 1 financial instrument. The Company’s bank accounts are maintained with financial institutions of reputable credit, therefore, bear minimal credit risk.

 

Recently Issued Accounting Pronouncements

 

On January 1, 2017, the Company adopted the accounting pronouncement issued by the Financial Accounting Standards Board (“FASB”) to simplify the presentation of deferred income taxes within the balance sheet. This pronouncement eliminates the requirement that deferred tax assets and liabilities are presented as current or noncurrent based on the nature of the underlying assets and liabilities. Instead, the pronouncement requires that all deferred tax assets and liabilities, including valuation allowances, be classified as noncurrent. We adopted this pronouncement on a retrospective basis. The adoption of this guidance did not have a material impact on the Company’s unaudited condensed financial position and/or results of operations.

 

On January 1, 2017, the Company adopted the accounting pronouncement issued by the FASB to simplify the accounting for goodwill impairment. This guidance eliminates the requirement that an entity calculate the implied fair value of goodwill when measuring an impairment charge. Instead, an entity would record an impairment charge based on the excess of a reporting unit’s carrying amount over its fair value. The Company adopted this pronouncement on a prospective basis. The adoption of this guidance did not have a material impact on the Company’s unaudited condensed financial position and/or results of operations.

 

In February 2016, an accounting pronouncement was issued by the FASB to replace existing lease accounting guidance. This pronouncement is intended to provide enhanced transparency and comparability by requiring lessees to record right-of-use assets and corresponding lease liabilities on the balance sheet for most leases. Expenses associated with leases will continue to be recognized in a manner similar to current accounting guidance. This pronouncement is effective for annual and interim periods beginning after December 15, 2018, with early adoption permitted. The adoption is required to be applied on a modified retrospective basis for each prior reporting period presented. The Company has not yet determined the effect that the adoption of this pronouncement may have on its unaudited condensed financial position and/or results of operations.

 

 
F-7
 
Table of Contents

 

Gripevine, Inc.

Notes to Condensed Combined Financial Statements

For The Three Months Ended May 31, 2017

(Expressed in US dollars)

 

5. EQUIPMENT

 

 

 

As at

May 31,

 

 

As at

February 28

 

 

 

2017

 

 

2017

 

 

 

$

 

 

$

 

Furniture

 

 

33,115

 

 

 

31,889

 

Computer equipment 

 

 

26,697

 

 

 

24,864

 

Total cost

 

 

59,812

 

 

 

56,753

 

Less: Accumulated depreciation

 

 

(20,721 )

 

 

(15,098 )

 

 

 

39,091

 

 

 

41,655

 

 

6. LOANS PAYABLE/DUE TO RELATED PARTIES / DUE TO A SHAREHOLDER

 

Loans payable

 

Loans payable represents advances from a related corporation to meet the working capital requirements of the Company. These advances are interest free, unsecured and are repayable on demand.

 

Due to related parties and due to a shareholder

 

The balances due to related parties and a shareholder are mainly in connection with the consulting services and financing provided for the development of an online complaint resolution platform as explained in Note 1 to the condensed combined financial statements. These balances are interest free, unsecured and are repayable on demand.

 

7. STOCKHOLDERS’ DEFICIENCY

 

Share Exchange Agreement

 

On February 28, 2017, the Company, MBE and the shareholders of MBE entered into a Share Exchange Agreement (the “Share Exchange Agreement”). The Board of Directors of the Company approved the execution and consummation of the transaction under the Share Exchange Agreement on February 28, 2017.

 

In accordance with the terms and provisions of the Share Exchange Agreement, the Company is to issue an aggregate of 5,248,626 shares of its restricted common stock to the MBE Shareholders in exchange for 157,458,778 of the total issued and outstanding shares of MBE (constituting 100%), thus making MBE its wholly-owned subsidiary. The Board of Directors of the Company and MBE deemed it in the best interests of the respective shareholders to enter into the Share Exchange Agreement pursuant to which the Company would acquire all the technology and assets and assume all liabilities of MBE.

 

 
F-8
 
Table of Contents

 

Gripevine, Inc.

Notes to Condensed Combined Financial Statements

For The Three Months Ended May 31, 2017

(Expressed in US dollars)

 

7. STOCKHOLDERS’ DEFICIENCY (continued)

 

Authorized stock

 

On October 31, 2016, the Board of Directors of the Company authorized an increase in the Company's shares of common stock to three hundred million (300,000,000) shares with par value remaining at $0.001 and creation of twenty million (20,000,000) shares of preferred stock, par value $0.001. On November 4, 2016, the Company filed a Certificate of Amendment with the Nevada Secretary of State increasing its authorized capital to 300,000,000 shares of common stock, par value $0.001, and 20,000,000 shares of preferred stock, par value $0.001 (the “Amendment). The Amendment was effective with the Nevada Secretary of State on November 4, 2016 when the Certificate of Amendment was filed. The Amendment was approved by the Board of Directors pursuant to written consent resolutions dated October 31, 2016 and further approved by the shareholders holding a majority of the total issued and outstanding shares of common stock of the Company pursuant to written consent resolutions dated October 31, 2016.

 

Common stock

 

On May 31, 2016 and effective October 3, 2016, the Company’s previous majority shareholder, sole executive officer and member of the Board of Directors, entered into those certain stock purchase agreements (collectively, the “Stock Purchase Agreements”) with certain individuals and/or entities (collectively, the “Investors”). In accordance with the terms and provisions of the Stock Purchase Agreements, the then majority shareholder sold and transferred at a per share price of $0.037 the control block of the Company consisting of 5,000,000 shares of restricted common stock and representing approximately 62.5% of the total issued and outstanding shares of common stock.

 

As at May 31, 2017 and February 28, 2017, the Company has 120,000,000 outstanding common stock (comprising of 75,000,000 restricted stock and 45,000,000 unrestricted stock).

 

In addition, as at May 31, 2017 and February 28, 2017, 5,248,626 shares of restricted common stock are to be issued pursuant to Share Exchange Agreement.

 

Preferred stock

 

On April 20, 2017, the Board of Directors authorized the issuance of the 1,000,000 shares of Series A Preferred Stock to its sole executive officer and member of the Board of Directors in consideration of his services performed during the year ended February 28, 2017. These preferred stock contain certain rights and preference as detailed below:

 

 

· In the event of acquisition of the Company, the preferred stock holder to receive 20% of the aggregate valuation of such merger;

 

 

 

 

· The holder can convert each share of preferred stock into 100 shares of common stock; and

 

 

 

 

· Each holder of preferred stock shall be entitled to cast 200 votes.

   

The fair value of these 1,000,000 preferred stock amounting to $38,694,414 was determined by an independent valuation using the assumptions i-e conversion value, control premium of 11.15% based on similar publicly trading companies, voting and sale/merger rights of the stock and stock price of $0.69. As the issuance of preferred stock related to past services, therefore, this amount was recorded as stock based compensation in the condensed combined statements of operations during the previous year ended February 28, 2017. The charge relating to three months ended May 31, 2016 amounts to $9,673,603. There was no such charge for the three months ended May 31, 2017.

 

 
F-9
 
Table of Contents

 

Gripevine, Inc.

Notes to Condensed Combined Financial Statements

For The Three Months Ended May 31, 2017

(Expressed in US dollars)

 

7. STOCKHOLDERS’ DEFICIENCY (continued)

 

Warrants

 

On December 1, 2016, the Company issued 18,275,000 warrants to certain shareholders of the Company for their services for the year ended February 28, 2017. These warrants have a strike price of $0.40 and will expire on December 1, 2019. The fair value of these warrants were measured at the date of grant using the Black-Scholes option pricing model using the following assumptions:

 

 

· Forfeiture rate of 0%;

 

 

 

 

· Stock price of $0.12 per share;

 

 

 

 

·

Exercise price of $0.4 per share;

 

 

 

 

· Volatility at 265.20 %;

 

 

 

 

· Risk free interest rate of 1.45%;

 

 

 

 

· Expected life of 3 years; and

 

 

 

 

· Expected dividend rate of 0%

 

At grant date the fair value of these warrants was determined at $2,110,333. As the issuance of warrants related to past services, therefore, this amount was recorded as stock based compensation in the combined statements of operations during the year (fourth quarter) ended February 28, 2017.

 

As at May 31, 2017 and February 28, 2017, there were 18,275,000 warrants were outstanding, fully vested and with a remaining contractual life term of 2.50 and 2.75 years, respectively.

 

 
F-10
 
Table of Contents

 

Gripevine, Inc.

Notes to Condensed Combined Financial Statements

For The Three Months Ended May 31, 2017

(Expressed in US dollars)

 

8. RELATED PARTY TRANSACTIONS AND BALANCES

 

The Company’s transactions with related parties were carried out on normal commercial terms and in the normal course of the Company’s business.

 

Other than disclosed elsewhere in the unaudited condensed combined financial statements, the related party transactions and balances are as follows:

 

Research and development expenses for the three months ended May 31, 2017 and 2016 include consulting charges from shareholders and related parties of $56,998 and $81,694 respectively.

 

9. COMMITMENTS

 

On March 8, 2016, the Company entered into an operating lease contract for its office premises in Oakville, Ontario for a three year and eight months term commenced from May 1, 2016. The monthly lease payment is between $3,350 to $4,890 plus applicable taxes.

 

On December 6, 2016, the Company entered into a second operating lease contract for its additional office premises in Oakville, Ontario for a three year term commenced from January 1, 2017. The monthly lease payment is between $2,500 to $3,800 plus applicable taxes.

 

10. SUBSEQUENT EVENTS

 

The Company’s management has evaluated subsequent events up to July 17, 2017, the date these unaudited condensed combined financial statements were issued, pursuant to the requirements of ASC 855 and has determined that there are no material subsequent events to report.

 

 
F-11
 
Table of Contents

  

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULTS OF OPERATIONS.

 

The following discussion of our financial condition, changes in financial condition, plan of operations and results of operations should be read in conjunction with our unaudited interim combined financial statements for the three months ended May 31, 2017 and 2016, together with the notes thereto included in this Form 10-Q. The discussion contains forward-looking statements that involve risks, uncertainties and assumptions. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of many factors.

 

OVERVIEW

 

Gripevine, Inc. (formerly Baixo Relocation Services, Inc. (the "Company") was incorporated in the state of Nevada on January 7, 2014. The Company operated as a relocation service provider for clients moving to the State of Goa, India and ceased this business and engaged in developing and building an online resolution platform after the Share Exchange Agreement as explained in the foregoing paragraph. The Company's fiscal year-end is February end.

 

MBE Holdings Inc. (“MBE”) was incorporated as a limited liability company on April 13, 2010 under the laws of the State of Delaware. MBE is engaged in research and development activities to offer an online complaint resolution platform for consumers and business, including ratings, reviews and polling’s. As such, its efforts to date have been devoted in building technology that enables access to this market through the development of a tangible product. 

 

As explained in the foregoing paragraph, on February 28, 2017, the Company and MBE and the shareholders of MBE who collectively own 100% of MBE entered into and consummated transactions pursuant to a Share Exchange Agreement, whereby the Company agreed to issue to the MBE shareholders an aggregate of approximately 5,248,626 shares of its common stock, par value $0.001, in exchange for 100% of equity interests of MBE held by the MBE shareholders. As a result of the share exchange, MBE became a wholly owned subsidiary of Gripevine.

 

Changes in Control of Registrant

 

Dated May 31, 2016 and effective October 3, 2016, Rosy Rodrigues (“Rodrigues”), our prior majority shareholder, sole executive officer and member of the Board of Directors, entered into those certain stock purchase agreements (collectively, the “Stock Purchase Agreements”) with certain individuals and/or entities (collectively, the “Investors”). In accordance with the terms and provisions of the Stock Purchase Agreements, Rodrigues sold and transferred at a per share price of $0.037 the control block of the Company consisting of 5,000,000 shares of restricted common stock and representing approximately 62.5% of the total issued and outstanding shares of common stock. Therefore, there was a change in control

 

 
5
 
Table of Contents

 

Submission of Matters to a Vote of Security Holders

 

On December 9, 2016, the majority shareholders of the Company approved a forward stock split of fifteen for one (15:1) of our total issued and outstanding shares of common stock (the “Stock Split”) and a change in our name from "Baixo Relocation Services Inc." to "Gripevine Inc." (the "Name Change"). Pursuant to our Bylaws and the Nevada Revised Statutes, a vote by the holders of at least a majority of our outstanding votes is required to effect the Stock Split and the Name Change. Our articles of incorporation do not authorize cumulative voting. As of the record date of December 9, 2016, we had 8,000,000 voting shares of common stock issued and outstanding. The consenting stockholders of the shares of common stock are entitled to 4,300,000 votes, which represents approximately 53.75% of the voting rights associated with our shares of common stock. The consenting stockholders voted in favor of the Stock Split and the Name Change described herein in a unanimous written consent dated December 9, 2016.

 

The Board of Directors had previously considered factors regarding their approval of the Stock Split including, but not limited to: (i) current trading price of our shares of common stock on the OTCQB Market and potential to increase the marketability and liquidity of our common stock; (ii) possible reluctance of brokerage firms and institutional investors to recommend lower-priced stocks to their clients or to hold in their own portfolios; (iii) desire to meet future requirements of per-share price and net tangible assets and shareholders’ equity relating to admission for trading on other markets; (iv) desire to mitigate short sellers and the adverse impact on the marketplace and trading of our shares; and (v) contemplation of proposed transaction with a corporate entity resulting in change of business operations. The Board of Directors of the Company approved the Name Change and the Stock Split and recommended the majority shareholders review and approve the Name Change and the Stock Split.

 

Amendment to Articles of Incorporation - Name Change and Forward Stock Split

 

T he Amendment was filed with the Secretary of State of Nevada on December 22, 2016 changing the name of the Company to "Gripevine Inc." (the "Name Change"). The Name Change was effected to better reflect the future business operations of the Company. Our new trading symbol is “GRPV”.

 

The Stock Split was effected as of January 5, 2017 based upon the filing of appropriate documentation with FINRA. The Stock Split increased our total issued and outstanding shares of common stock from approximately 8,000,000 shares to 120,000,000 shares of common stock. The common stock will continue to be $0.001 par value.

 

The new cusip number for the Company is 39861P 100.

 

Share Exchange Agreement

 

Effective February 28, 2017, we entered into a share exchange agreement (the “Share Exchange Agreement”) with MBE Holdings Inc., a private corporation organized under the laws of Delaware (“MBE”) and the shareholders of MBE (the “MBE Shareholders”). Our Board of Directors approved the execution and consummation of the transaction under the Share Exchange Agreement on February 28, 2017. The Board of Directors and the shareholders holding a majority of the total issued and outstanding shares of common stock of MBE authorized and approved the Share Exchange Agreement. In accordance with the Delaware Business Corporation Act, “a majority of the total issued and outstanding shares is required to approve an arrangement, which is defined as "a reconstruction under which a company transfer or sell or proposes to transfer or to sell to another company the whole or a substantial part of its undertaking for a consideration consisting in whole or in part of shares of securities of the other company ..."

 

 
6
 
Table of Contents

 

In accordance with the terms and provisions of the Share Exchange Agreement, an aggregate of 5,248,626 post-Stock Split shares of our restricted common stock are to be issued to the MBE Shareholders in exchange for 157,458,778 of the total issued and outstanding shares of MBE (constituting 100%), thus making MBE our wholly-owned subsidiary. As of the date of this Quarterly Report, the transfer agent has not yet issued the shares in certificate form. Our Board of Directors deemed it in the best interests of the respective shareholders to enter into the Share Exchange Agreement pursuant to which we would acquire all the technology and assets and assume all liabilities of MBE. This resulted in a change in overall business operations of the Company bringing potential value to our shareholders.

 

MBE provided to us the reviewed balance sheet and statements of operation, stockholders’ equity and cash flows as of and for the quarter ended September 30, 2016 and had certain assets and liabilities reflected on the balance sheet as follows: (i) current assets of $33,317 consisting of $28,301 in cash and $5,016 in prepaid and other receivables; (ii) long term assets of $21,648 consisting of equipment; (iii) current liabilities of $2,473,352 consisting of $13,720 in accrued liabilities, $1,949,118 due to related parties and $510,514 due to shareholder. In accordance with the terms and provisions of the Share Exchange Agreement, we agreed to assume such liabilities.

 

MBE is currently our wholly-owned subsidiary pursuant to the terms and provisions of the Share Exchange Agreement.

 

Since consummation of the Share Exchange Agreement resulting in MBE being our wholly-owned subsidiary, we are involved in the ongoing development and marketing of “Gripevine”, which is a social customer experience platform for social customer service and consumer reviews. “Gripevine” includes a proprietary process to assist companies in resolving customer service complaints (the “Gripevine Proprietary Process” or “Gripevine”). The Gripevine Proprietary Process helps consumers achieve resolutions while enabling businesses to improve consumer loyalty. Our platform includes the handling of ratings, reviews, complaint resolution statuses while offering data collection features such as scoring, polling, comments, voting, and credibility points – all with the aim of creating a home for connections, resolution, business improvement, and loyalty enhancement. Consumers with legitimate customer service complaints can post it (“plant a gripe”) and connect with companies who in turn can interact with their customers on a level playing field to find an amicable resolution.

 

Unlike other review sites that cater specifically to accumulating and displaying consumer feedback, the Gripevine business model offers significant value to both consumers and businesses. Management of the Corporation believes that the Gripevine Proprietary Process brings fairness and balance by: (i) ensuring users are real; (ii) allowing companies to reach out and verify customer identity; (iii) flagging as fake those consumers who are not identifiable; and (iv) providing companies free access to their customers. Gripevine’s unique proposition in this social customer experience space is to create consumer-company connections in order to drive loyalty through efficient and effective handling of online customer feedback and commentary.

 

RESULTS OF OPERATIONS

 

The following discussions are based on our interim condensed combined financial statements, including our wholly owned subsidiary. These charts and discussions summarize our financial statements for the three month period ended May 31, 2017 and May 31, 2016, and should be read in conjunction with the Company’s audited combined financial statements for the years ended February 28, 2017 and February 29, 2016 and notes thereto included in the Form 10-K filed with the SEC on June 14, 2017.

 

 
7
 
Table of Contents

 

The following discussion contains forward-looking statements that reflect our plans, estimates and beliefs. The Corporation’s actual results could differ materially from those discussed in the forward looking statements. Factors that could cause or contribute to such differences include, but are not limited to those discussed below and elsewhere in this Quarterly Report on Form 10-Q. The financial statements are stated in United States Dollars and are prepared in accordance with United States Generally Accepted Accounting Principles.

 

Three Month Period Ended May 31, 2017 Compared to Three Month Period Ended May 31, 2016

 

Revenue. We did not generate any revenue during the three month periods ended May 31, 2017 or May 31, 2016.

 

Operating expenses: During the three month period ended March 31, 2017, we incurred operating expenses in the amount of $347,604 compared to operating expenses incurred during the three month period ended May 31, 2016 of $9,930,897 (a decrease of $9,583,293). Operating expenses include: (i) general and administrative of $96,652 (2016: $67,728); and (ii) research and development expenses of $250,952 (2016: $189,566). General and administrative expenses increased by $28,924 mainly due to office rent for the additional office space and professional fees for increased scope of work. Research and development expenses increased by $61,386 based on engagement of new consultants for increased scale and scope of work. Stock based compensation of $9,7673,603 represents issuance of 1,000,000 preference share recorded in the previous year ended February 28, 2017.

 

Translation Adjustment. During the three month period ended May 31, 2017, we incurred a translation adjustment of $48,295 compared to $24,417 incurred during the three month period ended May 31, 2016 representing change in foreign exchange rate as a result of translating transaction and balances of Canadian based subsidiary.

 

Comprehensive income (loss). Thus, this resulted in comprehensive loss of ($395,899) or ($0.003) per share for the three month period ended May 31, 2017 compared to a comprehensive loss of ($9,955,314) or ($0.083) per share for the three month period ended May 31, 2016. The weighted average number of shares outstanding was 120,000,000 for both three month periods ended May 31, 2017 and May 31, 2016, respectively, taking into effect the Stock Split.

 

LIQUIDITY AND CAPITAL RESOURCES

 

Three Month Period Ended May 31, 2017

 

As at the three month period ended May 31, 2017, our current assets were $73,643 and our current liabilities were $2,988,987, which resulted in a working capital deficit of $2,915,344. As of the three month period ended May 31, 2017, current assets were comprised of: (i) $56,069 in cash; and (ii) $17,574 in prepaid and other receivables. As at the three month period ended May 31, 2017, current liabilities were comprised of: (i) $26,329 in accounts payable; (ii) $93,663 in accrued liabilities; (iii) $2,109,723 in loans payable; (iv) $166,975 due to related parties; and (v) $592,297 due to shareholder.

 

As of the three month period ended May 31, 2017, our total assets were $112,734 comprised of: (i) current assets of $73,643; and (ii) equipment, net of depreciation of $39,091. The increase in total assets during the three month period ended May 31, 2017 from fiscal year ended February 28, 2017 was primarily due to an increase in cash of $23,391.

 

As of the three month period ended May 31, 2017, our total liabilities were $2,988,987 comprised of current liabilities. The increase of $317,429 in total liabilities during the three month period ended May 31, 2017 from fiscal year ended February 28, 2017 was primarily due to an increase in loans payable of $286,770, accrued liabilities of $14,836, accounts payable of $4,004, and amounts due to a shareholder of $23,750 offset by decrease in due to related parties of $11,931.

 

Stockholders’ deficit increased from ($2,576,944) for fiscal year ended February 28, 2017 to ($2,876,253) for the three month period ended May 31, 2017.

 

 
8
 
Table of Contents

  

Cash Flows from Operating Activities

 

We have generated negative cash flows from operating activities. For the three month period ended May 31, 2017, net cash flows used in operating activities was ($318,524) compared to ($255,979) for the three month period ended May 31, 2016. Net cash flows provided by operating activities consisted primarily of net loss of ($347,604) (2016: $9,930,897), which was adjusted by non-cash transactions of $5,914 (2016: $2,672) in depreciation and stock based compensation of $nil (2016: $9,673,603). Net cash flows provided by operating activities was further changed by: (i) an increase of $2,500 (2016: ($1,911)) in prepaid expenses and other receivables; (ii) an increase of $4,335 (2016: $554) in accounts payable; and (iii) an increase of $16,331 (2016: $nil) in accrued liabilities.

 

Cash Flows from Investing Activities

 

We used cash of $4,123 in investing activities during the three month period ended May 31, 2017 which consisted of purchase of equipment. We used cash of $8,816 in investing activities during the three month period ended May 31, 2016 in purchase of equipment.

 

Cash Flows from Financing Activities

 

Net cash flows provided from financing activities during the three month period ended May 31, 2017 was $341,526, which consisted of $321,004 in loans payable, offset by ($13,876) due to related parties and $34,398 due to a shareholder. During the three month period ended May 31, 2016, cash flows provided by financing activities was $265,158, which consisted of $307,603 in loans payable and $39,548 due to a shareholder, which was offset by ($81,993) due to related parties.

 

Material Commitments

 

The balances due to related parties and shareholder are interest free, unsecured and are repayable on demand. The balances due to related parties and shareholders are mainly in connection with the services and financing provided for the development of an online complaint resolution platform.

 

Off-Balance Sheet Arrangements

 

There were no off-balance sheet arrangements during the three month period ended May 31, 2017 that have, or are reasonably likely to have, a current or future effect on our financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to our interests.

 

 
9
 
Table of Contents

 

PLAN OF OPERATION

 

As at May 31, 2017, we had an accumulated deficit of $46,982,573 and we will require additional financing in order to enable us to proceed with our plan of operations. When we will require additional financing, there can be no assurance that additional financing will be available to us, that it can be obtained on commercially reasonable terms. If we are not able to obtain the additional financing on a timely basis, we will not be able to meet our other obligations as they become due. We are pursuing various alternatives to meet our immediate and long-term financial requirements.

 

We anticipate continuing to rely on equity sales of our common stock in order to fund our business operations. Issuances of additional shares will result in dilution to existing stockholders. There is no assurance that we will achieve any additional sales of equity securities or arrange for debt or other financing to fund our planned business activities.

 

Our auditor has issued a going concern opinion. This means that there is substantial doubt that we can continue as an on-going business for the next twelve months unless we generate sufficient revenues. There is no assurance we will ever reach that point. In the meantime the continuation of the Company is dependent upon the continued financial support from our shareholders, our ability to obtain necessary equity financing to continue operations and the attainment of profitable operations.

 

Our operations and financial results are subject to various risks and uncertainties that could adversely affect our business, financial condition and results of operations.

 

We require approximately $150,000 for the next 12 months as a reporting issuer and additional funds are required. Before generation of revenue, the additional funding may come from equity financing from the sale of our common stock or loans from management or related third parties. In the event we do not raise sufficient capital to implement its planned operations or divest, your entire investment could be lost.

 

We have not paid any sums for public relations or investor relations.

 

ITEM 3. QUALITATIVE AND QUNTITATIVE DISCLOSURE ABOUT MARKET RISKS

 

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

 

 
10
 
Table of Contents

 

ITEM 4. CONTROLS AND PROCEDURES

 

DISCLOSURE CONTROLS AND PROCEDURES

 

Pursuant to Rule 13a-15(b) under the Securities Exchange Act of 1934 (“Exchange Act”), the Company carried out an evaluation, with the participation of the Company’s management, including the Company’s Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”) (the Company’s principal financial and accounting officer), of the effectiveness of the Company’s disclosure controls and procedures (as defined under Rule 13a-15(e) under the Exchange Act) as of the end of the period covered by this report. Based upon that evaluation, the Company’s CEO and CFO concluded that the Company’s disclosure controls and procedures are not effective as of May 31, 2017 to ensure that information required to be disclosed by the Company in the reports that the Company files or submits under the Exchange Act, is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to the Company’s management, including the Company’s CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure for the reason described below.

 

Because of our limited operations, we have limited number of employees which prohibits a segregation of duties. In addition, we lack a formal audit committee with a financial expert. As we grow and expand our operations we will engage additional employees and experts as needed. However, there can be no assurance that our operations will expand.

 

CHANGES IN INTERNAL CONTROL OVER FINANCIAL REPORTING

 

There were no changes in our internal control over financial reporting that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

 
11
 
Table of Contents

 

PART II - OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

The Company currently is not a party to any legal proceedings and, to the Company’s knowledge; no such proceedings are threatened or contemplated.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

SERIES A PREFERRED STOCK

 

On April 20, 2017, the Board of Directors authorized issuance of the 1,000,000 shares of Series A Preferred Stock to its sole executive officer and member of the Board of Directors, Richard Hue, based upon recognition of the outstanding services, leadership and innovative business operational strategies provided by Mr. Hue and his continuous dedication and loyalty to us, including undertaking of the development of the Gripevine technology.

 

The shares of Series A Preferred Stock carry certain rights and preferences, including voting rights consisting of two hundred votes for each one shares of Series A Preferred Stock. The shares of Series A Preferred Stock are convertible into shares of common stock on a one-for-one hundred basis, i.e. one share of Series A Preferred Stock for one hundred shares of common stock.

 

The share of Series A Preferred Stock were issued to Mr. Hue as a non-U.S. resident in reliance on Regulation S promulgated under the United States Securities Act of 1933, as amended (the “Securities Act”). The 1,000,000 shares of Series A Preferred Stock were issued at a per share price of $0.001. Neither the shares of Series A Preferred Stock nor the underlying shares of common stock have been registered under the Securities Act or under any state securities laws and may not be offered or sold without registration with the United States Securities and Exchange Commission or an applicable exemption from the registration requirements. Mr. Hue acknowledged that the securities to be issued have not been registered under the Securities Act, that he understood the economic risk of an investment in the securities, and that he had the opportunity to ask questions of and receive answers from the Company’s management concerning any and all matters related to acquisition of the securities.

  

 
12
 
Table of Contents

 

Share Purchase Warrants

 

On January 13, 2017, the Board of Directors authorized the execution of those certain share purchase warrant nos. 1 through 27 dated effective December 1, 2016 (collectively, the “Share Purchase Warrants”) with certain shareholders of the Company. The terms and provisions of the Share Purchase Warrants provide for the issuance of an aggregate 13,162,500 warrants (the “Warrants”). The Warrants are exercisable into 13,162,500 post-Forward Stock Split shares of the Company’s restricted common stock for a period of three years commencing December 1, 2016 and expiring December 1, 2019 at an exercise price of $0.40 per share.

 

As of the date of this Current Report, there are an aggregate of 120,000,000 post-Forward Stock Split shares of common stock issued and outstanding. Thus, the issuance of the Share Purchase Warrants represents approximately 10.97% of the total issued and outstanding shares.

  

ITEM 3. DEFAULT UPON SENIOR SECURITIES

 

None

 

ITEM 4. MINE SAFETY DISCLOSURES

 

None

 

ITEM 5. OTHER INFORMATION

 

No report required.

 

 
13
 
Table of Contents

 

ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K

 

The following exhibits are filed as part of this Form 10-Q:

 

Exhibit Number

Description

 

31.1

Certification of Principal Executive Officer Required By Rule 13a-14(A) of the Securities Exchange Act of 1934, As Amended, As Adopted Pursuant To Section 302 of the Sarbanes-Oxley Act of 2002*

 

 

 

31.2

 

Certification of Principal Financial Officer Required By Rule 13a-14(A) of the Securities Exchange Act of 1934, As Amended, As Adopted Pursuant To Section 302 of the Sarbanes-Oxley Act of 2002*

 

32.1

Certification of Principal Executive Officer and Principal Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*

 

101

 

XBRL Interactive Data Files

 

 
14
 
Table of Contents

  

SIGNATURES

 

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereto duly authorized.

 

GRIPEVINE INC.

Date: July 17, 2017

By:

/s/ Richard Hue

Richard Hue

Chief Executive Officer/President, Secretary,

Treasurer/Chief Financial Officer and Director 

 

 

15

 

flooidCX (PK) (USOTC:FLCX)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more flooidCX (PK) Charts.
flooidCX (PK) (USOTC:FLCX)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more flooidCX (PK) Charts.